These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30951192)

  • 1. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
    BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition.
    Grenville ZS; Noor U; Rinaldi S; Gunter MJ; Ferrari P; Agnoli C; Amiano P; Catalano A; Chirlaque MD; Christakoudi S; Guevara M; Johansson M; Kaaks R; Katzke V; Masala G; Olsen A; Papier K; Sánchez MJ; Schulze MB; Tjønneland A; Tong TYN; Tumino R; Weiderpass E; Zamora-Ros R; Key TJ; Smith-Byrne K; Schmidt JA; Travis RC
    Int J Cancer; 2024 Oct; ():. PubMed ID: 39378119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective analysis of circulating metabolites and endometrial cancer risk.
    Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
    Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer.
    Grenville ZS; Noor U; His M; Viallon V; Rinaldi S; Aglago EK; Amiano P; Brunkwall L; Chirlaque MD; Drake I; Eichelmann F; Freisling H; Grioni S; Heath AK; Kaaks R; Katzke V; Mayén-Chacon AL; Milani L; Moreno-Iribas C; Pala V; Olsen A; Sánchez MJ; Schulze MB; Tjønneland A; Tsilidis KK; Weiderpass E; Winkvist A; Zamora-Ros R; Key TJ; Smith-Byrne K; Travis RC; Schmidt JA
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
    Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
    BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium.
    Geijsen AJMR; van Roekel EH; van Duijnhoven FJB; Achaintre D; Bachleitner-Hofmann T; Baierl A; Bergmann MM; Boehm J; Bours MJL; Brenner H; Breukink SO; Brezina S; Chang-Claude J; Herpel E; de Wilt JHW; Gicquiau A; Gigic B; Gumpenberger T; Hansson BME; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Keski-Rahkonen P; Keulen ETP; Koole JL; Leeb G; Ose J; Schirmacher P; Schneider MA; Schrotz-King P; Stift A; Ulvik A; Vogelaar FJ; Wesselink E; van Zutphen M; Gsur A; Habermann N; Kampman E; Scalbert A; Ueland PM; Ulrich AB; Ulrich CM; Weijenberg MP; Kok DE
    Int J Cancer; 2020 Jun; 146(12):3256-3266. PubMed ID: 31495913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
    Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
    J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
    Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V
    BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
    Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
    Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.
    Dahm CC; Gorst-Rasmussen A; Crowe FL; Roswall N; Tjønneland A; Drogan D; Boeing H; Teucher B; Kaaks R; Adarakis G; Zylis D; Trichopoulou A; Fedirko V; Chajes V; Jenab M; Palli D; Pala V; Tumino R; Ricceri F; van Kranen H; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Luján-Barroso L; Larrañaga N; Chirlaque MD; Ardanaz E; Johansson M; Stattin P; Khaw KT; Wareham N; Wark PA; Norat T; Riboli E; Key TJ; Overvad K
    Am J Clin Nutr; 2012 Dec; 96(6):1354-61. PubMed ID: 23134890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
    Carayol M; Leitzmann MF; Ferrari P; Zamora-Ros R; Achaintre D; Stepien M; Schmidt JA; Travis RC; Overvad K; Tjønneland A; Hansen L; Kaaks R; Kühn T; Boeing H; Bachlechner U; Trichopoulou A; Bamia C; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Quirós JR; Sánchez-Cantalejo E; Huerta JM; Ardanaz E; Arriola L; Agudo A; Nilsson J; Melander O; Bueno-de-Mesquita B; Peeters PH; Wareham N; Khaw KT; Jenab M; Key TJ; Scalbert A; Rinaldi S
    J Proteome Res; 2017 Sep; 16(9):3137-3146. PubMed ID: 28758405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
    Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
    Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
    Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor.
    Huang J; Mondul AM; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
    Oncotarget; 2017 Jul; 8(28):45190-45199. PubMed ID: 28423352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival.
    Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Mondul AM; Sampson JN; Albanes D
    J Gerontol A Biol Sci Med Sci; 2019 May; 74(6):853-859. PubMed ID: 29878065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.
    Key TJ; Appleby PN; Allen NE; Travis RC; Roddam AW; Jenab M; Egevad L; Tjønneland A; Johnsen NF; Overvad K; Linseisen J; Rohrmann S; Boeing H; Pischon T; Psaltopoulou T; Trichopoulou A; Trichopoulos D; Palli D; Vineis P; Tumino R; Berrino F; Kiemeney L; Bueno-de-Mesquita HB; Quirós JR; González CA; Martinez C; Larrañaga N; Chirlaque MD; Ardanaz E; Stattin P; Hallmans G; Khaw KT; Bingham S; Slimani N; Ferrari P; Rinaldi S; Riboli E
    Am J Clin Nutr; 2007 Sep; 86(3):672-81. PubMed ID: 17823432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.